Immunotherapies are one of the fastest growing treatment algorithms in pharma at the moment, and non-small cell lung cancer (NSCLC) is just one area of oncology that is going to make the transition into being dominated by this type of therapy. Not only that, but this focus will help to triple the value of the NSCLC market by 2023.
Our newest infographic will allow you to explore the key events up to 2023 that will make immunotherapies a key treatment type in NSCLC, and the key players in this field.
What will you learn from this infographic?
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: